Somaxon Pharmaceuticals Inc (SOMX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
440 STEVENS AVENUE,, SUITE 200, SOLANA BEACH, CA 92075
(858) 876-6500

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 21.57 Million Shares Outstanding7.19 Million Avg 30-day Volume 45.507 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.27
Price to Revenue0.0 Debt to Equity0.0 EBITDA-199 Thousand
Price to Book Value6.2721 Operating Margin0.0 Enterprise Value8.478 Million
Current Ratio1.459 EPS Growth0 Quick Ratio1.333
1 Yr BETA 0.61 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth71.4217 Altman Z-Score-32.5721 Free Cash Flow to Firm 0
View SEC Filings from SOMX instead.

View recent insider trading info

Somaxon Pharmaceuticals Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SOMX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SOMX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HALE DAVID F

  • Director
 No longer subject to file 2013-03-06 0

MAST ERLE T

  • Director
 No longer subject to file 2013-03-06 0

EMSTER KURT VON

  • Director
 No longer subject to file 2013-03-06 0

EAGLE MICHAEL L

  • Director
 No longer subject to file 2013-03-06 0

PASCOE RICHARD W PRESIDENT AND CEO

  • Officer
  • Director
 No longer subject to file 2013-03-06 0

COBB TERRELL

  • Director
 No longer subject to file 2013-03-06 0

HASNAIN FAHEEM

  • Director
 No longer subject to file 2013-03-06 0

ONAITIS MATTHEW SVP, GENERAL COUNSEL

  • Officer
 No longer subject to file 2013-03-06 0

DORSEY BRIAN SVP, TECHNICAL OPERATIONS

  • Officer
 No longer subject to file 2013-03-06 0

NGUYEN TRAN SVP AND CFO

  • Officer
 No longer subject to file 2013-03-06 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
 1,117,592 2012-12-12 0

EVNIN LUKE

GALAKATOS NICHOLAS

HENNER DENNIS

STEINMETZ MICHAEL

SIMON NICHOLAS J III

WHEELER KURT

GADICKE ANSBERT

  • 10% Owner
 No longer subject to file 2012-07-06 0

MPM BIOVENTURES III-QP L.P.

MPM BIOVENTURES III LLC

MPM ASSET MANAGEMENT INVESTORS 2005 BVIII LLC

MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

MPM BIOVENTURES III PARALLEL FUND, L.P.

MPM BIOVENTURES III L.P.

MPM BIOVENTURES III GP L.P.

  • 10% Owner
 No longer subject to file 2012-07-06 0

WIGGANS THOMAS G

  • Director
 122,287 2012-07-02 0

ALLEN MICHAEL D SVP, SALES AND MARKETING

  • Officer
 0 2011-09-30 0

RASER JEFFREY SVP, CHIEF COMMERCIAL OFFICER

  • Officer
 106,667 2011-03-07 0

TREU JESSE I

  • Director
 No longer subject to file 2010-06-09 0

MONTREUX EQUITY PARTNERS II SBIC LP

MONTREUX EQUITY MANAGEMENT II SBIC LLC

MONTREUX EQUITY PARTNERS III SBIC L P

MONTREUX EQUITY MANAGMENT III SBIC

PALEFSKY HOWARD D

TURNER DANIEL K III

  • 10% Owner
 No longer subject to file 2010-03-18 0

WHEELER KURT

  • Director
  • 10% Owner
 4,689,939 2009-12-31 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

  • MEMBER OF 13(D) GROUPMEMBER OF 13(D) GROUPMEMBER OF 13(D) GROUP
 No longer subject to file 2009-08-26 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

LEWIS JOSEPH

MVA INVESTORS, LLC

  • MEMBER OF 13(D) GROUPMEMBER OF 13(D) GROUPMEMBER OF 13(D) GROUPMEMBER OF 13(D) GROUP
 1,776,595 2009-07-08 0

EVNIN LUKE

GALAKATOS NICHOLAS

HENNER DENNIS

STEINMETZ MICHAEL

GADICKE ANSBERT

SIMON NICHOLAS J III

  • 10% Owner
 5,909,155 2009-07-08 0

BAVP, L.P.

SCALE VENTURE MANAGEMENT I, LLC

BOCK LOUIS C

MITCHELL KATE

O'DRISCOLL RORY

BROOKS MARK J

  • 10% Owner
 3,002,858 2009-07-08 0

LITALIEN JAMES J SVP REGULATORY AFFAIRS & QA

  • Officer
 64,164 2009-02-17 0

JONES ROBERT LEWIS VP OF HUMAN RESOURCES

  • Officer
 65,429 2009-02-17 0

DUBE SUSAN SENIOR VP, CORP AND BUS DEV

  • Officer
 111,386 2009-02-17 0

MCGILLEY MEG VP, CFO, TREASURER

  • Officer
 75,887 2009-02-17 0

JOCHELSON PHILIP SENIOR VP AND CHIEF MEDICAL

  • Officer
 52,500 2008-11-28 0

TURNER DANIEL K III

  • Director
 0 2008-06-11 0

COHEN KENNETH M PRESIDENT AND CEO

  • Officer
  • Director
 58,795 2007-10-08 0

GARNER CAM L

  • Director
 71,027 2007-06-01 0

GLENN SCOTT L

  • Director
 335,831 2007-05-15 0

BLAIR JAMES C

  • 10% Owner
 1,749,624 2006-12-21 0

VITULLO NICOLE

  • 10% Owner
 25,838 2006-09-18 0

DOVEY BRIAN H

  • 10% Owner
 25,838 2006-09-18 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
 25,838 2006-09-18 0

MORE ROBERT J

  • 10% Owner
 25,838 2006-09-18 0

DP VI ASSOCIATES, L.P.

  • 10% Owner
 25,838 2006-09-18 0

DOMAIN PARTNERS VI, L.P.

  • 10% Owner
 2,285,789 2006-09-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments